Experts warn of potential consequences following Texas abortion pill ruling.

A US appeals court is set to decide on the FDA's approval of the medication abortion drug mifepristone after a Texas judge suspended it, bypassing the federal system set up to determine what drugs should be allowed on the market. Legal scholars, scientists, and drugmakers are concerned that the decision could start a trend of drugs being targeted in courts, creating a chilling effect on drug development in the US and hurting patients in the process. Vaccines, antidepressants, and psychotropic medicines could be at risk, some said.